Bio-SF
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- $2.1M
Investors
- 5
About Bio-SF
, Ltd. focuses on evaluating the safety of medical products. Bio-SF specializes in the evaluation of the efficacy and safety of medical devices, biomaterials, pharmaceuticals, and combination products. The company operates a comprehensive suite of services tailored to meet the rigorous standards of medical and clinical research, primarily through its state-of-the-art laboratory facilities, which span 4,114 square meters. Key offerings include an animal testing center, a testing center, and a training center, designed to support the development and regulatory approval of medical products. The client base primarily consists of pharmaceutical companies, medical device manufacturers, and research institutions seeking to ensure compliance with international safety standards. The company serves both domestic and international markets, providing essential services to clients in North America, Europe, and Asia. Bio-SF generates revenue through a structured transaction model that encompasses direct services to clients within the medical and pharmaceutical industries. The firm engages in business-to-business (B2B) interactions, providing specialized testing and evaluation services on a contractual basis. Clients may enter into agreements for comprehensive testing packages, which may include a series of assessments tailored to specific regulatory requirements. The company’s flagship services are positioned as critical components in the product development lifecycle, and pricing structures are determined based on the complexity and scope of services rendered. Revenue is derived from these service contracts, contributing to a stable financial foundation for the company.
Who invested in Bio-SF
5 investors across 2 rounds
See all investors in Bio-SF
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bio-SF
Who invested in Bio-SF?
Bio-SF has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bio-SF raised?
Bio-SF has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Bio-SF last raise money?
Bio-SF's most recent round on record is a Series A, in Oct 2025.
What does Bio-SF do?
Bio-SF is a biotechnology company.
Where is Bio-SF headquartered?
Bio-SF is headquartered in Changshu, China.
Which VCs invest in companies like Bio-SF?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Bio-SF's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Bio-SF? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.